{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T04:15:33Z","timestamp":1751429733519,"version":"3.41.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Civilian-Oriented Horizontal Research Project","award":["H220971"],"award-info":[{"award-number":["H220971"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-05747-x","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T15:24:56Z","timestamp":1751383496000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["High GOLT1A expression induces poor prognosis in papillary thyroid carcinoma"],"prefix":"10.1038","volume":"15","author":[{"given":"Tianjiao","family":"Ding","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiyu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanjia","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zihan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0614-2371","authenticated-orcid":false,"given":"Erli","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"5747_CR1","doi-asserted-by":"publisher","first-page":"925","DOI":"10.6004\/jnccn.2022.0040","volume":"20","author":"RI Haddad","year":"2022","unstructured":"Haddad, R. I. et al. Thyroid carcinoma, version 2.2022, NCCN clinical practice guidelines in oncology. J. Natl. Compr. Canc Netw. 20, 925\u2013951 (2022).","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"5747_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel, R. L., Giaquinto, A. N. & Jemal, A. Cancer statistics, 2024. CA Cancer J. Clin. 74, 12\u201349 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"5747_CR3","first-page":"425","volume":"331","author":"L Boucai","year":"2024","unstructured":"Boucai, L., Zafereo, M. & Cabanillas, M. E. Thyroid cancer. Rev. JAMA 331, 425\u2013435 (2024).","journal-title":"Thyroid Cancer: Rev. JAMA"},{"key":"5747_CR4","doi-asserted-by":"crossref","unstructured":"Hajeer, M. H., Awad, H. A., Abdullah, N. I., Almuhaisen, G. H. & Abudalu, L. E. The rising trend in papillary thyroid carcinoma. True increase or over diagnosis? Saudi Med. J. 39, 147\u2013153 (2018).","DOI":"10.15537\/smj.2018.2.21211"},{"key":"5747_CR5","doi-asserted-by":"crossref","unstructured":"Xu, S. & Han, Y. The overdiagnosis of thyroid micropapillary carcinoma: the rising incidence, inert biological behavior, and countermeasures. J. Oncol. 2021, 5544232 (2021).","DOI":"10.1155\/2021\/5544232"},{"key":"5747_CR6","doi-asserted-by":"publisher","first-page":"5012","DOI":"10.1158\/1078-0432.CCR-16-0484","volume":"22","author":"F Raue","year":"2016","unstructured":"Raue, F. & Frank-Raue, K. Thyroid cancer: Risk-Stratified management and individualized therapy. Clin. Cancer Res. 22, 5012\u20135021 (2016).","journal-title":"Clin. Cancer Res."},{"key":"5747_CR7","first-page":"409","volume":"62","author":"M Testini","year":"2007","unstructured":"Testini, M., Gurrado, A., Lissidini, G. & Nacchiero, M. Hypoparathyroidism after total thyroidectomy. Minerva Chir. 62, 409\u2013415 (2007).","journal-title":"Minerva Chir."},{"key":"5747_CR8","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1097\/PAP.0000000000000184","volume":"25","author":"MC Nath","year":"2018","unstructured":"Nath, M. C. & Erickson, L. A. Aggressive variants of papillary thyroid carcinoma: hobnail, tall cell, columnar, and solid. Adv. Anat. Pathol. 25, 172\u2013179 (2018).","journal-title":"Adv. Anat. Pathol."},{"key":"5747_CR9","doi-asserted-by":"publisher","first-page":"6646","DOI":"10.1038\/sj.onc.1208822","volume":"24","author":"TJ Giordano","year":"2005","unstructured":"Giordano, T. J. et al. Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET\/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis. Oncogene 24, 6646\u20136656 (2005).","journal-title":"Oncogene"},{"key":"5747_CR10","doi-asserted-by":"crossref","unstructured":"Ye, N. & Mn, N. Molecular genetics and diagnosis of thyroid cancer. Nat. Rev. Endocrinol. 7 (2011).","DOI":"10.1038\/nrendo.2011.142"},{"key":"5747_CR11","doi-asserted-by":"publisher","first-page":"450","DOI":"10.7150\/ijms.29935","volume":"16","author":"MI Abdullah","year":"2019","unstructured":"Abdullah, M. I. et al. Papillary thyroid cancer: genetic alterations and molecular biomarker investigations. Int. J. Med. Sci. 16, 450\u2013460 (2019).","journal-title":"Int. J. Med. Sci."},{"key":"5747_CR12","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.lfs.2019.03.034","volume":"223","author":"M Zarkesh","year":"2019","unstructured":"Zarkesh, M. et al. BRAF V600E mutation and MicroRNAs are helpful in distinguishing papillary thyroid malignant lesions: tissues and fine needle aspiration cytology cases. Life Sci. 223, 166\u2013173 (2019).","journal-title":"Life Sci."},{"key":"5747_CR13","doi-asserted-by":"publisher","first-page":"e32853","DOI":"10.1097\/MD.0000000000032853","volume":"102","author":"C Yang","year":"2023","unstructured":"Yang, C., Cao, Z. G., Zhou, Z. W. & Han, S. J. Circ0005654 as a new biomarker of thyroid cancer interacting with SP1 to influence the prognosis: A case-control study. Medicine 102, e32853 (2023).","journal-title":"Medicine"},{"key":"5747_CR14","doi-asserted-by":"publisher","first-page":"3934","DOI":"10.1093\/emboj\/18.14.3934","volume":"18","author":"S Conchon","year":"1999","unstructured":"Conchon, S., Cao, X., Barlowe, C. & Pelham, H. R. Got1p and Sft2p: membrane proteins involved in traffic to the golgi complex. EMBO J. 18, 3934\u20133946 (1999).","journal-title":"EMBO J."},{"key":"5747_CR15","doi-asserted-by":"publisher","first-page":"13170","DOI":"10.1038\/srep13170","volume":"5","author":"K Ikeda","year":"2015","unstructured":"Ikeda, K. et al. miR-378a-3p modulates Tamoxifen sensitivity in breast cancer MCF-7 cells through targeting GOLT1A. Sci. Rep. 5, 13170 (2015).","journal-title":"Sci. Rep."},{"key":"5747_CR16","doi-asserted-by":"publisher","first-page":"e12364","DOI":"10.1111\/cpr.12364","volume":"50","author":"L Zhang","year":"2017","unstructured":"Zhang, L. et al. Lidocaine inhibits the proliferation of lung cancer by regulating the expression of GOLT1A. Cell. Prolif. 50, e12364 (2017).","journal-title":"Cell. Prolif."},{"key":"5747_CR17","first-page":"461","volume":"37","author":"H Zi","year":"2022","unstructured":"Zi, H., Chen, L. & Ruan, Q. Lidocaine represses the malignant behavior of lung carcinoma cells via the circ_PDZD8\/miR-516b-5p\/GOLT1A axis. Histol. Histopathol. 37, 461\u2013474 (2022).","journal-title":"Histol. Histopathol"},{"key":"5747_CR18","doi-asserted-by":"publisher","first-page":"758643","DOI":"10.3389\/fonc.2021.758643","volume":"11","author":"DL Lin","year":"2021","unstructured":"Lin, D. L. et al. Gastrointestinal goblet cell adenocarcinomas harbor distinctive clinicopathological, immune, and genomic landscape. Front. Oncol. 11, 758643 (2021).","journal-title":"Front. Oncol."},{"key":"5747_CR19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.bbrc.2020.03.005","volume":"526","author":"L Zhang","year":"2020","unstructured":"Zhang, L. et al. GOLT1A-KISS1 fusion is associated with metastasis in adenoid cystic carcinomas. Biochem. Biophys. Res. Commun. 526, 70\u201377 (2020).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"5747_CR20","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.2147\/CCID.S370969","volume":"15","author":"H Xu","year":"2022","unstructured":"Xu, H. et al. BIRC7 is beneficial for melanoma progression and hypoxic response. Clin. Cosmet. Investig Dermatol. 15, 1109\u20131117 (2022).","journal-title":"Clin. Cosmet. Investig Dermatol."},{"key":"5747_CR21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3390\/pathogens11010046","volume":"11","author":"J Butterworth","year":"2021","unstructured":"Butterworth, J. et al. GOLT1B activation in hepatitis C Virus-Infected hepatocytes links ER trafficking and viral replication. Pathogens 11, 46 (2021).","journal-title":"Pathogens"},{"key":"5747_CR22","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/s12935-021-01991-z","volume":"21","author":"T Liu","year":"2021","unstructured":"Liu, T. et al. Vesicle transporter GOLT1B mediates the cell membrane localization of DVL2 and PD-L2 and promotes colorectal cancer metastasis. Cancer Cell. Int. 21, 287 (2021).","journal-title":"Cancer Cell. Int."},{"key":"5747_CR23","doi-asserted-by":"crossref","unstructured":"J, L. et al. Multi-Omics analyses revealed GOLT1B as a potential prognostic gene in breast Cancer probably regulating the immune microenvironment. Front. Oncol. 11 (2022).","DOI":"10.3389\/fonc.2021.805273"},{"key":"5747_CR24","doi-asserted-by":"publisher","first-page":"e96801","DOI":"10.1371\/journal.pone.0096801","volume":"9","author":"F Varghese","year":"2014","unstructured":"Varghese, F., Bukhari, A. B., Malhotra, R. & De, A. IHC profiler: an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples. PLoS One. 9, e96801 (2014).","journal-title":"PLoS One"},{"key":"5747_CR25","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH image to imagej: 25 years of image analysis. Nat. Methods. 9, 671\u2013675 (2012).","journal-title":"Nat. Methods"},{"key":"5747_CR26","doi-asserted-by":"publisher","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. https:\/\/doi.org\/10.3322\/caac.21834","DOI":"10.3322\/caac.21834"},{"key":"5747_CR27","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/S2213-8587(20)30115-7","volume":"8","author":"M Li","year":"2020","unstructured":"Li, M., Maso, D., Vaccarella, S. & L. & Global trends in thyroid cancer incidence and the impact of overdiagnosis. Lancet Diabetes Endocrinol. 8, 468\u2013470 (2020).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"5747_CR28","doi-asserted-by":"publisher","first-page":"04084","DOI":"10.7189\/jogh.14.04084","volume":"14","author":"S Hu","year":"2024","unstructured":"Hu, S., Wu, X. & Jiang, H. Trends and projections of the global burden of thyroid cancer from 1990 to 2030. J. Glob Health. 14, 04084 (2024).","journal-title":"J. Glob Health"},{"key":"5747_CR29","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.3390\/cells11131990","volume":"11","author":"D Spano","year":"2022","unstructured":"Spano, D. & Colanzi, A. Golgi complex: A signaling hub in Cancer. Cells 11, 1990 (2022).","journal-title":"Cells"},{"key":"5747_CR30","doi-asserted-by":"publisher","first-page":"815207","DOI":"10.3389\/fendo.2021.815207","volume":"12","author":"L Gao","year":"2021","unstructured":"Gao, L. et al. Large-Volume lateral lymph node metastasis predicts worse prognosis in papillary thyroid carcinoma patients with N1b. Front. Endocrinol. (Lausanne). 12, 815207 (2021).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"5747_CR31","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.humpath.2023.04.005","volume":"136","author":"MA Gubbiotti","year":"2023","unstructured":"Gubbiotti, M. A. et al. Does the presence of capsule influence prognosis in poorly differentiated thyroid carcinoma? Hum. Pathol. 136, 96\u2013104 (2023).","journal-title":"Hum. Pathol."},{"key":"5747_CR32","unstructured":"Ke, S., Xu, Z., Zhou, Y. & Zheng, C. Golgi transport 1A promotes cell proliferation and metastasis of papillary thyroid carcinoma. zggx 45, 69\u201375 (2024)."},{"key":"5747_CR33","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1089\/thy.2008.0164","volume":"18","author":"R Ghossein","year":"2008","unstructured":"Ghossein, R. & Livolsi, V. A. Papillary thyroid carcinoma tall cell variant. Thyroid 18, 1179\u20131181 (2008).","journal-title":"Thyroid"},{"key":"5747_CR34","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1089\/thy.2009.0352","volume":"20","author":"LGT Morris","year":"2010","unstructured":"Morris, L. G. T., Shaha, A. R., Tuttle, R. M., Sikora, A. G. & Ganly, I. Tall-cell variant of papillary thyroid carcinoma: a matched-pair analysis of survival. Thyroid 20, 153\u2013158 (2010).","journal-title":"Thyroid"},{"key":"5747_CR35","doi-asserted-by":"publisher","first-page":"40792","DOI":"10.18632\/oncotarget.8215","volume":"7","author":"X Wang","year":"2016","unstructured":"Wang, X., Cheng, W., Liu, C. & Li, J. Tall cell variant of papillary thyroid carcinoma: current evidence on clinicopathologic features and molecular biology. Oncotarget 7, 40792\u201340799 (2016).","journal-title":"Oncotarget"},{"key":"5747_CR36","doi-asserted-by":"publisher","first-page":"e1255","DOI":"10.1002\/iid3.1255","volume":"12","author":"R Darvishvand","year":"2024","unstructured":"Darvishvand, R. et al. Natural killer cell subsets and their functional molecules in peripheral blood of the patients with breast cancer. Immun. Inflamm. Dis. 12, e1255 (2024).","journal-title":"Immun. Inflamm. Dis."},{"key":"5747_CR37","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1002\/ijc.29030","volume":"136","author":"V Dumeaux","year":"2015","unstructured":"Dumeaux, V. et al. Peripheral blood cells inform on the presence of breast cancer: A population-based case\u2013control study. Int. J. Cancer. 136, 656\u2013667 (2015).","journal-title":"Int. J. Cancer"},{"key":"5747_CR38","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1158\/1078-0432.CCR-07-1801","volume":"14","author":"M Han","year":"2008","unstructured":"Han, M. et al. Novel blood-based, five-gene biomarker set for the detection of colorectal cancer. Clin. Cancer Res. 14, 455\u2013460 (2008).","journal-title":"Clin. Cancer Res."},{"key":"5747_CR39","doi-asserted-by":"publisher","first-page":"8271","DOI":"10.1111\/jcmm.16773","volume":"25","author":"Q Zhang","year":"2021","unstructured":"Zhang, Q. et al. Peripheral blood transcriptome heterogeneity and prognostic potential in lung cancer revealed by RNA-Seq. J. Cell. Mol. Med. 25, 8271\u20138284 (2021).","journal-title":"J. Cell. Mol. Med."},{"key":"5747_CR40","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.1158\/1078-0432.CCR-05-2081","volume":"12","author":"I Osman","year":"2006","unstructured":"Osman, I. et al. Novel blood biomarkers of human urinary bladder cancer. Clin. Cancer Res. 12, 3374\u20133380 (2006).","journal-title":"Clin. Cancer Res."},{"key":"5747_CR41","doi-asserted-by":"publisher","first-page":"104497","DOI":"10.1016\/j.ebiom.2023.104497","volume":"90","author":"S Hong","year":"2023","unstructured":"Hong, S. et al. Cell-free DNA methylation biomarker for the diagnosis of papillary thyroid carcinoma. eBioMedicine 90, 104497 (2023).","journal-title":"eBioMedicine"},{"key":"5747_CR42","doi-asserted-by":"publisher","first-page":"591","DOI":"10.2174\/1871530319666191018170022","volume":"20","author":"K Liu","year":"2020","unstructured":"Liu, K., Gao, M., Qin, D., Wang, H. & Lu, Q. Serous BMP8A has clinical significance in the ultrasonic diagnosis of thyroid cancer and promotes thyroid cancer cell progression. Endocr. Metab. Immune Disord Drug Targets. 20, 591\u2013598 (2020).","journal-title":"Endocr. Metab. Immune Disord Drug Targets"},{"key":"5747_CR43","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12916-024-03368-1","volume":"22","author":"F Wang","year":"2024","unstructured":"Wang, F. et al. Blood leukocytes as a non-invasive diagnostic tool for thyroid nodules: a prospective cohort study. BMC Med. 22, 147 (2024).","journal-title":"BMC Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05747-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05747-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05747-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T15:24:58Z","timestamp":1751383498000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05747-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5747"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-05747-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"8 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the First Affiliated Hospital of Soochow University (No.2025009) and the Ethics Committee of the First Affiliated Hospital of Wenzhou Medical University (No. KY2024-004).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication of the contents of Tables\u00a0 and .","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publish"}}],"article-number":"20979"}}